Protagonist Therapeutics (PTGX)
Discovers peptide medicines and earns collaboration economics from partnered ICOTYDE and rusfertide.
$145.71
vs last close+0.73 (+0.51%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 44 days
EPS estimate
$2.43
Revenue estimate
$240.1M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$1.98−$0.19−$0.55−$0.62−$0.69$0.05$2.29Pending
Estimate$0.06−$0.50−$0.53−$0.59−$0.53−$0.65$2.23$2.43
Surprise+3,200.0%+62.0%−3.8%−5.1%−30.2%+107.7%+2.7%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$170.6M$28.3M$5.5M$4.7M$7.4M$56.4M$213.5MPending
Estimate$81.0M$6.6M$8.4M$14.9M$8.7M$11.7M$202.7M$240.1M
Surprise+110.6%+332.0%−34.2%−68.4%−14.9%+381.7%+5.3%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $0.15 | — | — |
| Sep 2027 | $0.11 | — | — |
| Jun 2027 | −$0.03 | — | — |
| Mar 2027 | −$0.14 | — | — |
| Dec 2026 | −$0.26 | — | — |
| Nov 2026 | $2.43 | — | — |
| Aug 2026 | $2.23 | $2.29 | +2.7% |
| May 2026 | −$0.65 | $0.05 | +107.7% |
| Feb 2026 | −$0.53 | −$0.69 | −30.2% |
| Nov 2025 | −$0.59 | −$0.62 | −5.1% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Sep 2016 | |||
| Aug 2016 | |||
| Dec 2015 | |||
| Sep 2015 | |||
| Jun 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $0.15 | — | — | $111.9M | — | — | — |
| Sep 2027 | $0.11 | — | — | $65.2M | — | — | — |
| Jun 2027 | −$0.03 | — | — | $52.1M | — | — | — |
| Mar 2027 | −$0.14 | — | — | $48.5M | — | — | — |
| Dec 2026 | −$0.26 | — | — | $37.9M | — | — | — |
| Nov 5, 2026 | $2.43 | — | — | $240.1M | — | — | — |
| Aug 5, 2026 | $2.23 | $2.29 | +2.7% | $202.7M | $213.5M | +5.3% | +6.5% |
| May 5, 2026 | −$0.65 | $0.05 | +107.7% | $11.7M | $56.4M | +381.7% | +4.8% |
| Feb 25, 2026 | −$0.53 | −$0.69 | −30.2% | $8.7M | $7.4M | −14.9% | −0.3% |
| Nov 6, 2025 | −$0.59 | −$0.62 | −5.1% | $14.9M | $4.7M | −68.4% | +2.4% |
| Aug 6, 2025 | |||||||
| May 6, 2025 | |||||||
| Feb 21, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 6, 2024 | |||||||
| May 7, 2024 | |||||||
| Feb 27, 2024 | |||||||
| Nov 2, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 4, 2023 | |||||||
| Mar 15, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 4, 2022 | |||||||
| Feb 28, 2022 | |||||||
| Nov 3, 2021 | |||||||
| Aug 4, 2021 | |||||||
| May 4, 2021 | |||||||
| Mar 10, 2021 | |||||||
| Nov 4, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 7, 2020 | |||||||
| Mar 10, 2020 | |||||||
| Nov 6, 2019 | |||||||
| Aug 7, 2019 | |||||||
| May 8, 2019 | |||||||
| Mar 12, 2019 | |||||||
| Nov 6, 2018 | |||||||
| Aug 7, 2018 | |||||||
| May 9, 2018 | |||||||
| Mar 7, 2018 | |||||||
| Nov 6, 2017 | |||||||
| Aug 8, 2017 | |||||||
| May 10, 2017 | |||||||
| Mar 7, 2017 | |||||||
| Nov 14, 2016 | |||||||
| Sep 15, 2016 | |||||||
| Aug 12, 2016 | |||||||
| Dec 31, 2015 | |||||||
| Sep 30, 2015 | |||||||
| Jun 30, 2015 |